2,422 results match your criteria: "Ovarian Dysgerminomas"
Vet Radiol Ultrasound
January 2025
Department of Veterinary Medicine, Università degli Studi di Milano, Lodi, Italy.
The aim of this retrospective multicentric case series is to describe the CT findings of ovarian neoplasia in dogs. Twenty dogs with pre- and postcontrast CT exams and cytological/histological diagnosis of ovarian neoplasia were included. Five dogs presented with bilateral tumors, for a total of 25 neoplasms: 15 carcinomas (4 bilateral), 4 granulosa cell tumors, 2 poorly differentiated malignant neoplasia (bilateral), 2 luteomas, 1 teratoma, 1 dysgerminoma.
View Article and Find Full Text PDFZhonghua Bing Li Xue Za Zhi
December 2024
Department of Pathology, Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing100191, China.
To investigate the relationship between the expression patterns of SOX2 and FOXG1 and the differentiation/development level of neural components in immature teratoma and to determine the clinical significance and potential application of this correlation in a clinical setting. We conducted a comprehensive whole transcriptome sequencing analysis to identify differentially expressed genes (DEGs) across various subtypes of ovarian germ cell tumors. Additionally, immunohistochemical staining of paraffin-embedded tissue sections was employed to assess the nuclear staining pattern of SOX2 and FOXG1 proteins within the tumor tissues.
View Article and Find Full Text PDFBMC Vet Res
December 2024
Clinical Unit for Diagnostic Imaging, University of Veterinary Medicine, Vienna, Austria.
Cir Cir
November 2024
Servicio de Oncología Ginecológica, Unidad Médica de Alta Especialidad HGO 4 Luis Castelazo Ayala. Instituto Mexicano del Seguro Social, Ciudad de México, México.
Cureus
October 2024
Multidisciplinary Breast Clinic - Gynecologic Oncology, Antwerp University Hospital, Edegem, BEL.
Eur J Surg Oncol
October 2024
Division of Gynaecology and Obstetrics, Department of Gynaecology University Medical Centre Ljubljana, Slajmerjeva 3, 1000, Ljubljana, Slovenia; Medical Faculty, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.
Sci Rep
October 2024
Department of Medical Oncology, King Fahad Specialist Hospital, Eastern Health Cluster, Dammam, Saudi Arabia.
J Clin Res Pediatr Endocrinol
October 2024
Department of Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
Int J Gynaecol Obstet
September 2024
Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Republic of Korea.
Objective: To analyze and improve the accuracy of preoperative assessment and intraoperative frozen-section analysis (FSA) for malignant ovarian germ cell tumors (MOGCTs), especially in the context of fertility preservation.
Methods: A retrospective review of 48 women aged under 40 years, diagnosed with MOGCTs, and treated at Chonnam National University Hospital between July and December 2022 was conducted. The results of preoperative magnetic resonance imaging (MRI), measurement of serum tumor markers (α-fetoprotein [AFP], β-human chorionic gonadotropin, lactate dehydrogenase [LDH], cancer antigen [CA] 125, CA 19-9, CA 72-4, carcinoembryonic antigen), and intraoperative FSA were compared with the final pathology diagnosis.
Indian J Surg Oncol
September 2024
Department of Pathology, Jawaharlal Nehru Medical College and Hospital, AligarhMuslimUniversity, Aligarh, Uttar Pradesh India.
Ann Med Surg (Lond)
August 2024
Department of Laboratory Medicine.
Ovary dysgerminoma is one of the most good prognosis malignant tumor, which has a 5-year overall survival rate exceeding to 90%. Generally, the incidence of ovarian dysgerminoma (OD) is relatively low, accounting for ~0.6% of all ovarian tumors.
View Article and Find Full Text PDFCase Rep Womens Health
October 2024
Division of Gynecologic Oncology; WVU Cancer Institute Mary Babb Randolph Cancer Center; 1 Medical Center Drive, Morgantown, WV 26506, USA.
J Pediatr Endocrinol Metab
August 2024
Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Sichuan, China.
Int J Gynecol Cancer
December 2024
Department of Pediatrics, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
Minerva Obstet Gynecol
July 2024
Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Front Immunol
July 2024
Department of Neurology, The Central Hospital of Shaoyang, Shaoyang, China.
Int J Mol Sci
June 2024
Department of Morpho-Functional Sciences I-Histology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
Radiol Case Rep
August 2024
Service de radiologie, hôpital mère-enfant, CHU Hassan II, université Sidi Mohammed Benabdellah, Fès, Maroc.
Front Oncol
May 2024
Department of Pathology, The First Hospital of Jilin University, Changchun, China.
Clin Case Rep
June 2024
Institute of Anatomical Pathology, School of Medicine University Prishtina Prishtina Kosovo.
Key Clinical Message: Fertility-sparing surgery and appropriate adjuvant chemotherapy for advanced malignant ovarian germ cell tumors have excellent survival results and promising reproductive and obstetric outcomes.
Abstract: This case report aims to demonstrate the potential feasibility and success of fertility-sparing surgery (FSS) coupled with adjuvant chemotherapy in treating advanced malignant ovarian germ cell tumor (MOGCT), focusing on pure dysgerminoma, fertility, and achieving spontaneous pregnancy. The patient was a 23-year-old female who initially presented with complaints of abdominal distension and a palpable mass and was subsequently diagnosed with advanced MOGCT.
Zhonghua Bing Li Xue Za Zhi
June 2024
Department of Pathology, School of Basic Medical Sciences, Third Hospital, Peking University Health Science Center, Beijing 100191, China.
Indian J Surg Oncol
June 2024
Department of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan 302004 India.
Germ cell tumors encompass a broad spectrum of neoplasms arising from germ cell lineage, demonstrating varying histological profiles and clinical presentations. These tumors encompass a range of benign and malignant entities. While global trends provide insights into their prevalence, specific regional variations, such as those within North-Western India, remain less explored.
View Article and Find Full Text PDFMol Oncol
June 2024
Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil.
microRNAs (miRNAs) are small endogenous noncoding RNAs, and alterations in their expression may contribute to oncogenesis. Discovering a unique miRNA pattern holds the potential for early detection and novel treatment possibilities in cancer. This study aimed to evaluate miRNA expression in pediatric patients with gonadal germ cell tumors (GCTs), focusing on characterizing the miRNA profiles of each histological subtype and identifying a distinct histological miRNA signature for a total of 42 samples of pediatric gonadal GCTs.
View Article and Find Full Text PDFZhonghua Nan Ke Xue
July 2023
Department of Pathology, The People's Hospital of Jiangsu Province /The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Clin Oncol (R Coll Radiol)
June 2024
National Clinical Research Center for Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China. Electronic address: